CPRX insider transaction filings
CATALYST PHARMACEUTICALS, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen CPRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Thompson Tamar — Director | Disposition to issuer (D): 3,773 @ $31.50 · Disposition to issuer (D): 40,000 (derivative) @ $0 · Disposition to issuer (D): 29,524 (derivative) @ $0 · Disposition to issuer (D): 23,248 (derivative) @ $0 · Disposition to issuer (D): 18,115 (derivative) @ $0 · Disposition to issuer (D): 1,414 (derivative) @ $0 · +2 more | EDGAR |
| 2026-07-17 | 4 | Sundaram Preethi — Chief Strategy Officer | Disposition to issuer (D): 54,804 @ $31.50 · Disposition to issuer (D): 225,000 (derivative) @ $0 · Disposition to issuer (D): 67,500 (derivative) @ $0 · Disposition to issuer (D): 68,000 (derivative) @ $0 · Disposition to issuer (D): 143,193 (derivative) @ $0 · Disposition to issuer (D): 137,553 (derivative) @ $0 · +4 more | EDGAR |
| 2026-07-17 | 4 | Russo Gregg — Chief HR Officer | Disposition to issuer (D): 476 @ $31.50 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 6,957 (derivative) @ $0 · Disposition to issuer (D): 20,349 (derivative) @ $0 · Disposition to issuer (D): 20,531 (derivative) @ $0 · Disposition to issuer (D): 2,752 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-17 | 4 | Miller Steve — Chief Op. & Scientific Officer | Disposition to issuer (D): 1,093,803 @ $31.50 · Disposition to issuer (D): 180,000 (derivative) @ $0 · Disposition to issuer (D): 275,000 (derivative) @ $0 · Disposition to issuer (D): 185,000 (derivative) @ $0 · Disposition to issuer (D): 146,000 (derivative) @ $0 · Disposition to issuer (D): 248,004 (derivative) @ $0 · +5 more | EDGAR |
| 2026-07-17 | 4 | MCENANY PATRICK J — Director | Disposition to issuer (D): 4,171,559 @ $31.50 · Disposition to issuer (D): 740,000 (derivative) @ $0 · Disposition to issuer (D): 400,000 (derivative) @ $0 · Disposition to issuer (D): 270,000 (derivative) @ $0 · Disposition to issuer (D): 272,000 (derivative) @ $0 · Disposition to issuer (D): 73,810 (derivative) @ $0 · +5 more | EDGAR |
| 2026-07-17 | 4 | Kalb Michael Wayne — Chief Financial Officer | Disposition to issuer (D): 13,665 @ $31.50 · Disposition to issuer (D): 257,214 (derivative) @ $0 · Disposition to issuer (D): 169,248 (derivative) @ $0 · Disposition to issuer (D): 131,536 (derivative) @ $0 · Disposition to issuer (D): 21,416 (derivative) @ $0 · Disposition to issuer (D): 13,788 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-17 | 4 | Harper Molly — Director | Disposition to issuer (D): 3,694 @ $31.50 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 29,524 (derivative) @ $0 · Disposition to issuer (D): 23,248 (derivative) @ $0 · +4 more | EDGAR |
| 2026-07-17 | 4 | Elsbernd Brian — Chief Legal Officer | Disposition to issuer (D): 242,501 @ $31.50 · Disposition to issuer (D): 132,000 (derivative) @ $0 · Disposition to issuer (D): 200,000 (derivative) @ $0 · Disposition to issuer (D): 135,000 (derivative) @ $0 · Disposition to issuer (D): 69,000 (derivative) @ $0 · Disposition to issuer (D): 147,621 (derivative) @ $0 · +5 more | EDGAR |
| 2026-07-17 | 4 | Del Carmen Jeffrey — Chief Commercial Officer | Disposition to issuer (D): 14,337 @ $31.50 · Disposition to issuer (D): 150,000 (derivative) @ $0 · Disposition to issuer (D): 200,000 (derivative) @ $0 · Disposition to issuer (D): 135,000 (derivative) @ $0 · Disposition to issuer (D): 88,000 (derivative) @ $0 · Disposition to issuer (D): 167,918 (derivative) @ $0 · +5 more | EDGAR |
| 2026-07-17 | 4 | Daly Richard J — President and CEO, Director | Disposition to issuer (D): 271,266 @ $31.50 · Disposition to issuer (D): 33,500 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 1,365,319 (derivative) @ $0 · +5 more | EDGAR |
| 2026-07-17 | 4 | Curran Daniel J. — Director | Disposition to issuer (D): 40,000 (derivative) @ $0 · Disposition to issuer (D): 18,115 (derivative) @ $0 · Disposition to issuer (D): 5,468 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Andrews William T. — Chief Medical Officer | Disposition to issuer (D): 2,309 @ $31.50 · Disposition to issuer (D): 124,447 (derivative) @ $0 · Disposition to issuer (D): 98,652 (derivative) @ $0 · Disposition to issuer (D): 12,209 (derivative) @ $0 · Disposition to issuer (D): 29,776 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Tierney David S — Director | Disposition to issuer (D): 383,314 @ $31.50 · Disposition to issuer (D): 33,500 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 29,524 (derivative) @ $0 · +5 more | EDGAR |
| 2026-07-17 | 4 | DENKHAUS DONALD A — Director | Disposition to issuer (D): 498,773 @ $31.50 · Disposition to issuer (D): 33,500 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 29,524 (derivative) @ $0 · +5 more | EDGAR |
| 2026-06-05 | 4 | Andrews William T. — Chief Medical Officer | Option exercise (M): 3,052 · Tax withholding (F): 743 · Option exercise (M): 3,052 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Russo Gregg — Chief HR Officer | Option exercise (M): 687 · Tax withholding (F): 211 · Option exercise (M): 687 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Kalb Michael Wayne — Executive Vice President & CFO | Option exercise (M): 7,139 · Tax withholding (F): 2,080 · Option exercise (M): 7,139 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Daly Richard J — President and CEO, Director | Option exercise (M): 42,105 · Tax withholding (F): 10,577 · Option exercise (M): 42,105 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Sundaram Preethi — Chief Strategy Officer | Option exercise (M): 6,667 · Tax withholding (F): 2,369 · Option exercise (M): 6,667 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Miller Steve — Chief Op. & Scientific Officer | Option exercise (M): 14,000 · Option exercise (M): 14,000 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | MCENANY PATRICK J — Director | Option exercise (M): 26,334 · Tax withholding (F): 6,786 · Option exercise (M): 26,334 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Harper Molly — Director | Option exercise (M): 1,334 · Option exercise (M): 1,334 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Elsbernd Brian — Chief Compliance/Legal Officer | Option exercise (M): 6,667 · Tax withholding (F): 2,623 · Option exercise (M): 6,667 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Del Carmen Jeffrey — Chief Commercial Officer | Option exercise (M): 8,667 · Tax withholding (F): 3,839 · Option exercise (M): 8,667 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Daly Richard J — President and CEO, Director | Option exercise (M): 1,334 · Tax withholding (F): 524 · Option exercise (M): 1,334 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Tierney David S — Director | Option exercise (M): 1,334 · Option exercise (M): 1,334 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | DENKHAUS DONALD A — Director | Option exercise (M): 1,334 · Option exercise (M): 1,334 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Harper Molly — Director | Option exercise (M): 20,000 @ $5.78 · Sale (S): 15,527 @ $23.20 · Sale (S): 4,473 @ $23.73 · Sale (S): 6,746 @ $23.06 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Thompson Tamar — Director | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Sundaram Preethi — Chief Strategy Officer | Option exercise (M): 6,855 · Tax withholding (F): 1,669 · Option exercise (M): 6,855 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Miller Steve — Chief Op. & Scientific Officer | Option exercise (M): 11,873 · Option exercise (M): 11,873 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | MCENANY PATRICK J — Director | Option exercise (M): 3,534 · Option exercise (M): 3,534 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Harper Molly — Director | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Elsbernd Brian — Chief Compliance/Legal Officer | Option exercise (M): 7,067 · Tax withholding (F): 2,780 · Option exercise (M): 7,067 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Del Carmen Jeffrey — Chief Commercial Officer | Option exercise (M): 8,039 · Tax withholding (F): 2,492 · Option exercise (M): 8,039 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Tierney David S — Director | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | DENKHAUS DONALD A — Director | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | MCENANY PATRICK J — Director | Gift (G): 45,000 @ $0 · Gift (G): 45,000 @ $0 · Gift (G): 45,000 @ $0 | EDGAR |
| 2025-11-28 | 4 | Del Carmen Jeffrey — Chief Commercial Officer | Option exercise (M): 10,983 @ $4.21 · Sale (S): 10,983 @ $23.33 · Option exercise (M): 10,983 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Thompson Tamar — Director | Option exercise (M): 947 · Grant/award (A): 18,115 (derivative) @ $0 · Grant/award (A): 5,468 (derivative) @ $0 · Option exercise (M): 947 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Sundaram Preethi — Chief Strategy Officer | Option exercise (M): 5,603 · Tax withholding (F): 1,364 · Grant/award (A): 106,873 (derivative) @ $0 · Grant/award (A): 32,257 (derivative) @ $0 · Option exercise (M): 5,603 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Russo Gregg — Chief HR Officer | Grant/award (A): 20,531 (derivative) @ $0 · Grant/award (A): 6,197 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Miller Steve — Chief Op. & Scientific Officer | Option exercise (M): 8,267 · Grant/award (A): 158,454 (derivative) @ $0 · Grant/award (A): 47,826 (derivative) @ $0 · Option exercise (M): 8,267 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | MCENANY PATRICK J — Director | Option exercise (M): 1,775 · Grant/award (A): 34,921 (derivative) @ $0 · Grant/award (A): 10,540 (derivative) @ $0 · Option exercise (M): 1,775 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Kalb Michael Wayne — Executive Vice President & CFO | Option exercise (M): 6,894 · Tax withholding (F): 2,485 · Grant/award (A): 131,536 (derivative) @ $0 · Grant/award (A): 39,701 (derivative) @ $0 · Option exercise (M): 6,894 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Harper Molly — Director | Option exercise (M): 947 · Grant/award (A): 18,115 (derivative) @ $0 · Grant/award (A): 5,468 (derivative) @ $0 · Option exercise (M): 947 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Elsbernd Brian — Chief Compliance/Legal Officer | Option exercise (M): 5,161 · Tax withholding (F): 2,030 · Grant/award (A): 98,652 (derivative) @ $0 · Grant/award (A): 29,776 (derivative) @ $0 · Option exercise (M): 5,161 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Del Carmen Jeffrey — Chief Commercial Officer | Option exercise (M): 5,603 · Tax withholding (F): 1,641 · Grant/award (A): 106,873 (derivative) @ $0 · Grant/award (A): 32,257 (derivative) @ $0 · Option exercise (M): 5,603 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Daly Richard J — President and CEO, Director | Option exercise (M): 20,006 · Tax withholding (F): 7,872 · Grant/award (A): 381,948 (derivative) @ $0 · Grant/award (A): 115,283 (derivative) @ $0 · Option exercise (M): 20,006 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Curran Daniel J. — Director | Grant/award (A): 18,115 (derivative) @ $0 · Grant/award (A): 5,468 (derivative) @ $0 | EDGAR |
Recent 8-K events — CATALYST PHARMACEUTICALS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-16 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K/A | 8.01 — Other Events | EDGAR |
| 2026-03-18 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CPRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →